Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortCore leukaemia chemotherapy given as infusion or injection.Chemotherapy that also treats severe autoimmune disease.
Body systemCancerCancer
Drug classAntimetabolitesAlkylating agents
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesAcute myeloid leukaemia, Acute lymphoblastic leukaemia, Lymphoma (including CNS prophylaxis)Lymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplants
How it worksBlocks leukaemia cells from copying their DNA.Damages DNA so dividing cells die.
Starts workingDepends on the cancer and regimen—
Half-life1–3 hours—
Typical adult doseDosed by your cancer team according to the treatment protocol.Varies widely by condition and regimen.
FormsIV infusion, Subcutaneous injection, Intrathecal injectionIV infusion, Tablet
Common side effectsNausea, Fever and flu-like symptoms, Rash, Low blood counts, Mouth soresNausea, Hair loss, Low blood counts
Serious side effectsSevere infection from low white cells, Cerebellar toxicity (high dose), Conjunctivitis (high dose)Bleeding from the bladder, Infertility, Secondary cancers, Infections
Don't take ifPregnancy; Severe bone marrow suppression unless treating leukaemia—
AlcoholBest to limit. Alcohol can add to nausea and tiredness; ask your cancer team.—
PregnancyUsually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment.Usually avoidedCauses birth defects.
BreastfeedingUsually avoidedAvoid breastfeeding during treatment.—
In use since—1959
Brand namesUnited States: Cytarabine (generic)United Kingdom: Cytarabine (generic)India: Cytarabine (generic), CytosarUnited States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, Cyclomide
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H—
ATC codeL01BC01L01AA01

Taken together

  • ModerateCytarabine + Cyclophosphamide: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker